リアルタイムバイオセンサー市場レポート：動向、予測、競合分析 (2031年まで)

世界のリアルタイムバイオセンサー市場の将来は、糖尿病と神経系疾患市場に機会がありそうです。世界のリアルタイムバイオセンサー市場は、2025年から2031年にかけてCAGR 7.2％で成長する見込みです。この市場の主な促進要因は、迅速で正確な診断ソリューションに対する需要の増加、センサーの小型化を可能にするバイオテクノロジーの進歩、医療、食品安全、環境モニタリングにおけるアプリケーションの拡大です。

• Lucintelでは、種類別ではウェアラブルバイオセンサーが予測期間中に高い成長を遂げると予測しています。
• 用途別では、糖尿病がより高い成長を示す見込みです。
• 地域別では、欧州が予測期間で最も高い成長が見込まれています。

リアルタイムバイオセンサー市場の戦略的成長機会

リアルタイムバイオセンサー市場は、主要アプリケーションにおいて戦略的成長の機会を数多く提供しています。これに基づき、企業は市場での地位を高め、消費者の多様なニーズに応えることができます。

• 医療診断：医療分野は、特に診断分野においてリアルタイムバイオセンサーに大きな成長の可能性をもたらしています。この分野では現在、医療検査にスピードと正確さが求められており、革新的なバイオセンシング・ソリューションへの需要が高まっています。
• ウェアラブルヘルスモニター：ウェアラブルバイオセンサーへの熱意とともに、健康に関心を持つ消費者層が拡大しています。企業は、バイタルサインや身体活動、その他の健康指標をリアルタイムで追跡するモニターを製造することで、この動向を利用することができます。
• 食品安全のモニタリング：リアルタイムバイオセンサーは、汚染物質や病原体をモニターすることができるため、食品の安全性を保証する上できわめて重要です。これは、消費者がより厳しい食品安全基準を求めるようになるにつれて、引き続き重要なものとなります。
• 環境モニタリング：水質のモニタリングや汚染物質の検出など、環境アプリケーションの機会は急速に拡大しています。バイオセンサーは、持続可能な実践を促進し、公衆衛生の取り組みを強化するリアルタイムデータを提供できる可能性があります。
• スポーツとフィットネスへの応用：スポーツの世界では、バイオセンシング技術の採用が進んでいます。これは、アスリートのパフォーマンスや健康状態の測定がモニターされることを意味します。この開発動向は、アスリートやフィットネス愛好家のニーズに合わせた特殊なバイオセンシング技術を生み出す可能性を秘めています。

このような戦略的成長機会は、リアルタイムバイオセンサー市場拡大の道筋を浮き彫りにし、さまざまな産業の進化するニーズに基づく革新と適応を促します。

リアルタイムバイオセンサー市場の促進要因・課題

リアルタイムバイオセンサー市場は、その成長と開拓に影響を与えるいくつかの主要な促進要因・課題の影響を受けています。これらの要因を理解することは、市場情勢をナビゲートするプレーヤーにとって不可欠です。

リアルタイムバイオセンサー市場を牽引する要因は以下の通りです：

• 技術進歩：ナノテクノロジーや小型化などのセンサー技術の向上により、市場は急速に進歩しています。センシング能力の向上は、精度と使いやすさの点で製品に利益をもたらし、多様なアプリケーションでの利用を増加させます。
• 健康モニタリング需要の増加：健康とウェルネスに対する意識の高まりは、健康指標を簡単にモニタリングできるリアルタイムバイオセンサーを個人に求めるよう促しています。消費者は、長期間にわたって健康指標を監視する便利なソリューションを求めており、これが需要を増加させ、市場のさらなる成長に拍車をかけます。
• 政府のイノベーション支援：各国政府は、医療技術とバイオセンサーの技術革新への投資を増やしています。研究開発への支援により新製品の導入が加速し、市場が拡大します。
• 予防医療モデルの成長：予防医療モデルがバイオセンサーの採用を加速させています。リアルタイムのモニタリングにより健康問題を未然に察知できるため、医療支出を削減し、患者の回復率を高めることができます。
• デジタルヘルスソリューションとの統合：スマートフォンアプリや遠隔医療ネットワークなどのデジタルヘルスソリューションとバイオセンサの統合は、その有用性を高めます。この統合により、効率的なデータ管理が可能になり、患者のエンゲージメントが高まります。

リアルタイムバイオセンサー市場の課題は以下の通りです：

• 規制上の障壁：バイオセンサー業界のメーカーは、数多くの規制に直面しています。これらの規制への対応は、タイムリーな製品開発と市場投入を複雑にしています。
• 高い開発コスト：高度なバイオセンシング技術の研究開発にはコストがかかります。小規模企業は、資本力のある大企業との競争に苦戦する可能性があります。
• データプライバシーに関する懸念の高まり：バイオセンサーには機密性の高い健康情報が含まれるため、プライバシーとデータセキュリティに対する懸念が高まっています。消費者の信頼を獲得し、普及を促進するためには、こうした問題に対処することが不可欠です。

これらの促進要因・課題はすべて相互に関連しており、リアルタイムバイオセンサー市場に大きな影響を与えています。既存の促進要因を活用することで、企業は適切な時期に実施される的を絞った戦略によって課題を軽減することができます。

目次

第1章 エグゼクティブサマリー

第2章 世界のリアルタイムバイオセンサー市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のリアルタイムバイオセンサー市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のリアルタイムバイオセンサー市場：種類別
  • 非ウェアラブルバイオセンサー
  • ウェアラブルバイオセンサー
• 世界のリアルタイムバイオセンサー市場：用途別
  • 糖尿病
  • 神経系疾患
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のリアルタイムバイオセンサー市場：地域別
• 北米のリアルタイムバイオセンサー市場
• 欧州のリアルタイムバイオセンサー市場
• アジア太平洋のリアルタイムバイオセンサー市場
• その他地域のリアルタイムバイオセンサー市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のリアルタイムバイオセンサー市場の成長機会：種類別
  • 世界のリアルタイムバイオセンサー市場の成長機会：用途別
  • 世界のリアルタイムバイオセンサー市場の成長機会：地域別
• 世界のリアルタイムバイオセンサー市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のリアルタイムバイオセンサー市場の生産能力拡大
  • 世界のリアルタイムバイオセンサー市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Abbott Laboratories
• Dexcom
• Medtronic
• Ascensia Diabetes Care
• Roche
• Lifescan
• ARKRAY
• Sinocare
• Nova Biomedical
• B. Braun

The future of the global real-time biosensor market looks promising with opportunities in the diabetes and nervous system disease markets. The global real-time biosensor market is expected to grow with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are increasing demand for rapid and accurate diagnostic solutions, advancements in biotechnology enabling sensor miniaturization, and growing applications in healthcare, food safety, and environmental monitoring.

• Lucintel forecasts that, within the type category, the on-wearable biosensor is expected to witness higher growth over the forecast period.
• Within the application category, diabetes is expected to witness a higher growth.
• In terms of regions, Europe is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Real-Time Biosensor Market

Emerging trends are those that are progressively evolving within the real-time biosensors market. Technological advancements and shifts in consumer demands will lead to emerging trends in real-time biosensing application fields.

• Integration with IoT: IoT platforms have integrated real-time biosensors into the framework in a manner that makes data collection and analysis more efficient. With this trend, health conditions monitored and managed are improved through remote patient management and better decision-making during clinical practice.
• Wearable Technology Expansion: Market expansion will be supplemented by wearable technology growth. The application of wearable technology is one of the main factors contributing to growth in this market. Sensors are becoming smaller and can be applied to more vital aspects, such as continuous monitoring of important parameters required in personal health management.
• Focus on Multiplexing: Nowadays, biosensors that detect multiple biomarkers are in high demand. This multiplexing allows for more accurate and efficient disease diagnosis, enabling doctors to make informed decisions based on comprehensive data.
• Advancements in Material Science: Recent developments in material science are changing the sensitivity and specificity of real-time biosensors with nanomaterials and biocompatible materials. The latter makes it possible to design sensors that can be used in various conditions and environments.
• Regulatory Support and Standardization: Regulatory support and standardization will be significant driving factors in the growing biosensor market. The need for assurance of the safety and efficacy of biosensing technologies is becoming increasingly important to build trust among consumers and pave the way for market growth.

These emerging trends are reshaping the landscape of the real-time biosensors market by enhancing capabilities, broadening applications, and improving user experiences in health monitoring and diagnostics.

Recent Developments in the Real-Time Biosensor Market

The real-time biosensors market has gained significant technological and application developments to make biosensing solutions more effective and easily accessible. These significant developments are driving the evolution of this market.

• Portable Devices: Recent developments involve the commercial availability of portable biosensing devices that users can utilize on the go to monitor specific health indicators. These devices are convenient and empower individuals to take responsibility for their health.
• Non-invasive Sensors: Advances in non-invasive sensors have led to the creation of more accurate biosensors that do not require blood samples. These devices offer better patient comfort and compliance for health monitoring.
• Integration of Machine Learning Algorithms: Biosensing technologies are being combined with machine learning algorithms, advancing data analysis capabilities for real-time insights and predictive analytics to enhance clinical decision-making processes.
• Focus on Environmental Applications: Recent developments include biosensors designed not only for medical purposes but also for environmental applications, such as monitoring water adulteration with pollutants and pathogens. This is critical for public health and safety in developing regions.
• Collaborative Research Initiatives: The advantages of advancements in the technological innovation of biosensor devices stem from the involvement of academia and industry in collaborative interdisciplinary research. These efforts lead to advancements in sensing materials and methods, expanding their potential utilization in biosensing.

These advancements prominently benefit the real-time biosensors market by providing better product offerings and expanding the field of applications in health and environmental monitoring.

Strategic Growth Opportunities for Real-Time Biosensor Market

The real-time biosensors market presents numerous opportunities for strategic growth in key applications. Based on this, companies can enhance their market position and meet the diverse needs of consumers.

• Healthcare Diagnostics: The healthcare sector offers significant growth prospects for real-time biosensors, particularly in the diagnostics segment. The sector now necessitates speed and accuracy in medical testing, increasing the demand for innovative biosensing solutions.
• Wearable Health Monitors: There is an expanding consumer base concerned about health, along with enthusiasm for wearable biosensors. Companies can capitalize on this trend by producing monitors that track real-time vital signs, physical activity, and other health metrics.
• Food Safety Monitoring: Real-time biosensors can be crucial for providing food safety assurance, as they can monitor contaminants and pathogens. This will remain critical as consumers demand stricter food safety standards.
• Environmental Monitoring: There are rapidly growing opportunities in environmental applications, including monitoring aquatic quality and detecting pollutants. Biosensors may provide real-time data that can facilitate sustainable practices and enhance public health efforts.
• Applications in Sports and Fitness: The sporting world increasingly adopts biosensing technology. This means the performance and health measurements of athletes are monitored. This developing trend offers the potential to create specialized biosensing technology tailored to the needs of athletes and fitness enthusiasts.

These strategic growth opportunities highlight avenues for expansion in the market for real-time biosensors, encouraging innovation and adaptation based on the evolving needs of various industries.

Real-Time Biosensor Market Driver and Challenges

The real-time biosensors market is influenced by several key drivers and challenges that affect its growth and development. Understanding these factors is vital for any players navigating the market landscape.

The factors responsible for driving the real-time biosensor market include:

• Technological Advancements: The market is rapidly advancing with sensor technology improvements, such as nanotechnology and miniaturization. Enhanced sensing capabilities benefit products in terms of accuracy and user-friendliness, which increases their usage across diverse applications.
• Increased Demand for Health Monitoring: Growing awareness about health and wellness has prompted individuals to seek real-time biosensors for easy monitoring of health metrics. Consumers require convenient solutions to monitor their health metrics over extended periods, which will increase demand and fuel further market growth.
• Government Innovation Support: Governments are investing more in healthcare technology and innovation in biosensors. Support for research and development accelerates the introduction of new products, thus expanding the market.
• Growing Preventive Healthcare Model: The preventive healthcare model is accelerating the adoption of biosensors. Real-time monitoring can detect health problems before they occur, reducing healthcare expenditures and increasing recovery rates among patients.
• Integration with Digital Health Solutions: The integration of biosensors with digital health solutions, including smartphone apps and telehealth networks, enhances their utility. This integration allows for efficient data management and increases patient engagement.

Challenges in the real-time biosensor market are:

• Regulatory Barriers: Manufacturers in the biosensor industry face numerous regulations. Compliance with these regulations complicates timely product development and market launch.
• High Development Costs: Research and development for advanced biosensing technologies are costly. Small firms may struggle to compete with larger firms that have more capital resources.
• Increasing Concerns about Data Privacy: Biosensors contain sensitive health information, leading to rising concerns about privacy and data security. Addressing these issues is essential for gaining consumer confidence and promoting widespread adoption.

All these drivers and challenges are interconnected and significantly impact the real-time biosensors market. By leveraging the existing drivers, companies can mitigate challenges through targeted strategies implemented at appropriate times.

List of Real-Time Biosensor Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, real-time biosensor companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time biosensor companies profiled in this report include-

• Abbott Laboratories
• Dexcom
• Medtronic
• Ascensia Diabetes Care
• Roche
• Lifescan
• ARKRAY
• Sinocare
• Nova Biomedical
• B. Braun

Real-Time Biosensor by Segment

The study includes a forecast for the global real-time biosensor market by type, application, and region.

Real-Time Biosensor Market by Type [Analysis by Value from 2019 to 2031]:

• Non-Wearable Biosensor
• Wearable Biosensor

Real-Time Biosensor Market by Application [Analysis by Value from 2019 to 2031]:

• Diabetes
• Nervous System Disease
• Others

Real-Time Biosensor Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Real-Time Biosensor Market

The real-time biosensors market is experiencing rapid advancements due to innovative technology and a growing demand for reliable health monitoring solutions. This growth supports leading development companies in the United States, China, Germany, India, and Japan-all focusing on the ability of biosensors to enhance healthcare, monitor environmental hazards, and ensure food safety. Significant progress has been made in miniaturization, IoT integration, and improvements in sensitivity and specificity as industries adopt real-time biosensing technologies.

• United States: Recently, the U.S. has focused on nanomaterial innovation integrated with advanced materials at the sensing material level to enhance sensor performance. Companies are concentrating on wearable biosensors that monitor patients' vital signs and biochemical markers to improve outcomes in chronic disease care. Partnerships between tech companies and healthcare institutions promote innovation toward new products utilizing machine learning in predictive analytics for health monitoring.
• China: China has recently increased investments in real-time biosensor technology, driven by government initiatives in the health sector. Recent successes indicate the potential for developing low-cost, high-performance biosensors to aid in diabetes management and diagnose infectious diseases. Chinese companies are also working to integrate biosensors with mobile applications, enhancing access to real-time data sharing and monitoring, which is vital for public health responses.
• Germany: Germany is currently focusing on precision and quality in the development of real-time biosensors. Recent innovations include biosensors capable of diagnosing various biomarkers simultaneously, thereby improving diagnostic accuracy for clinicians. Companies are investing in the miniaturization of sensors to provide portable diagnostic tools. Collaborations with research institutions have established Germany as a key player in the European biosensor market.
• India: The market for real-time biosensors in India is growing exponentially. There is a focus on developing affordable healthcare products, with recent advancements targeting biosensors relevant to rural applications, such as monitoring water purity and agricultural product health. Indian startups are creating low-cost, efficient biosensing technologies and facilitating their deployment in underserved communities, leading to improved access to essential health monitoring and environmental safety tools.
• Japan: Biosensors are finding extensive applications in real-time monitoring in Japan, particularly in robotics, smart devices, and other wearable products. Recent developments also include biosensors integrated into health wearables for easy monitoring. Companies are leveraging sensor technology to address food safety and environmental monitoring challenges.

Features of the Global Real-Time Biosensor Market

Market Size Estimates: Real-time biosensor market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Real-time biosensor market size by type, application, and region in terms of value ($B).

Regional Analysis: Real-time biosensor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the real-time biosensor market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time biosensor market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the real-time biosensor market by type (non-wearable biosensor and wearable biosensor), application (diabetes, nervous system disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-Time Biosensor Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Real-Time Biosensor Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Real-Time Biosensor Market by Type
  • 3.3.1: Non-wearable Biosensor
  • 3.3.2: Wearable Biosensor
• 3.4: Global Real-Time Biosensor Market by Application
  • 3.4.1: Diabetes
  • 3.4.2: Nervous System Disease
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Real-Time Biosensor Market by Region
• 4.2: North American Real-Time Biosensor Market
  • 4.2.1: North American Real-Time Biosensor Market by Type: Non-wearable Biosensor and Wearable Biosensor
  • 4.2.2: North American Real-Time Biosensor Market by Application: Diabetes, Nervous System Disease, and Others
• 4.3: European Real-Time Biosensor Market
  • 4.3.1: European Real-Time Biosensor Market by Type: Non-wearable Biosensor and Wearable Biosensor
  • 4.3.2: European Real-Time Biosensor Market by Application: Diabetes, Nervous System Disease, and Others
• 4.4: APAC Real-Time Biosensor Market
  • 4.4.1: APAC Real-Time Biosensor Market by Type: Non-wearable Biosensor and Wearable Biosensor
  • 4.4.2: APAC Real-Time Biosensor Market by Application: Diabetes, Nervous System Disease, and Others
• 4.5: ROW Real-Time Biosensor Market
  • 4.5.1: ROW Real-Time Biosensor Market by Type: Non-wearable Biosensor and Wearable Biosensor
  • 4.5.2: ROW Real-Time Biosensor Market by Application: Diabetes, Nervous System Disease, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Real-Time Biosensor Market by Type
  • 6.1.2: Growth Opportunities for the Global Real-Time Biosensor Market by Application
  • 6.1.3: Growth Opportunities for the Global Real-Time Biosensor Market by Region
• 6.2: Emerging Trends in the Global Real-Time Biosensor Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Real-Time Biosensor Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-Time Biosensor Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Dexcom
• 7.3: Medtronic
• 7.4: Ascensia Diabetes Care
• 7.5: Roche
• 7.6: Lifescan
• 7.7: ARKRAY
• 7.8: Sinocare
• 7.9: Nova Biomedical
• 7.10: B. Braun